Literature DB >> 15760631

Magnetic resonance spectroscopy in patients with MELAS.

Harald E Möller1, Gerhard Kurlemann, Manfred Pützler, Dirk Wiedermann, Thorsten Hilbich, Barbara Fiedler.   

Abstract

Localized magnetic resonance spectroscopy (MRS) yields sensitive metabolic markers to provide insight into the pathophysiology of mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) in vivo. Findings in full MELAS syndrome at 1H MRS of the brain typically include severely elevated lactate and reduced N-acetylaspartate, glutamate, myo-inositol, and total creatine concentrations in stroke-like lesions. Similar but less extreme alterations are also common in gray matter (GM) regions that appear normal at magnetic resonance imaging. Phosphorus spectroscopy of peripheral muscle permits investigation of the bioenergetic status. A decline of the phosphorylation potential indicates a low energy reserve at rest. Phosphocreatine resynthesis during post-exercise recovery is delayed pointing to reduced mitochondrial capacity. As MRS is inherently non-invasive, follow-up studies can be performed to assess treatment response quantitatively.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15760631     DOI: 10.1016/j.jns.2004.11.014

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  19 in total

Review 1.  [Cerebral CT and MRI in mitchondrial disorders].

Authors:  J Finsterer
Journal:  Nervenarzt       Date:  2009-06       Impact factor: 1.214

2.  Transient ischemic attack-like episodes without stroke-like lesions in MELAS.

Authors:  Tadahiro Mitani; Noriko Aida; Moyoko Tomiyasu; Takahito Wada; Hitoshi Osaka
Journal:  Pediatr Radiol       Date:  2013-05-16

3.  Tissue-specific splicing of an Ndufs6 gene-trap insertion generates a mitochondrial complex I deficiency-specific cardiomyopathy.

Authors:  Bi-Xia Ke; Salvatore Pepe; David R Grubb; Jasper C Komen; Adrienne Laskowski; Felicity A Rodda; Belinda M Hardman; James J Pitt; Michael T Ryan; Michael Lazarou; Jane Koleff; Michael M H Cheung; Joseph J Smolich; David R Thorburn
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

Review 4.  Imaging of MELAS.

Authors:  Konark Malhotra; David S Liebeskind
Journal:  Curr Pain Headache Rep       Date:  2016-09

5.  Mitochondrial dysfunction and cerebral metabolic abnormalities in patients with mitochondrial encephalomyopathy subtypes: Evidence from proton MR spectroscopy and muscle biopsy.

Authors:  Feng-Nan Niu; Hai-Lan Meng; Lei-Lei Chang; Hong-Yan Wu; Wei-Ping Li; Ren-Yuan Liu; Hui-Ting Wang; Bing Zhang; Yun Xu
Journal:  CNS Neurosci Ther       Date:  2017-07-11       Impact factor: 5.243

6.  Acute Cortical Lesions in MELAS Syndrome: Anatomic Distribution, Symmetry, and Evolution.

Authors:  K D Bhatia; P Krishnan; H Kortman; J Klostranec; T Krings
Journal:  AJNR Am J Neuroradiol       Date:  2019-12-05       Impact factor: 3.825

7.  The appearance of ADCs in the non-affected areas of the patients with MELAS.

Authors:  Zhenghua Liu; Xiwei Liu; Lihong Hui; Danhua Zhao; Xiaoying Wang; Sheng Xie; Jiangxi Xiao; Xuexiang Jiang
Journal:  Neuroradiology       Date:  2010-06-17       Impact factor: 2.804

Review 8.  In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.

Authors:  Erica B Sherry; Phil Lee; In-Young Choi
Journal:  Neurochem Res       Date:  2015-11-26       Impact factor: 3.996

9.  Detection of lactate with a hadamard slice selected, selective multiple quantum coherence, chemical shift imaging sequence (HDMD-SelMQC-CSI) on a clinical MRI scanner: Application to tumors and muscle ischemia.

Authors:  Eric A Mellon; Seung-Cheol Lee; Stephen Pickup; Sungheon Kim; Steven C Goldstein; Thomas F Floyd; Harish Poptani; E James Delikatny; Ravinder Reddy; Jerry D Glickson
Journal:  Magn Reson Med       Date:  2009-12       Impact factor: 4.668

10.  Cerebral metabolic abnormalities in A3243G mitochondrial DNA mutation carriers.

Authors:  Nora Weiduschat; Petra Kaufmann; Xiangling Mao; Kristin Marie Engelstad; Veronica Hinton; Salvatore DiMauro; Darryl De Vivo; Dikoma Shungu
Journal:  Neurology       Date:  2014-01-29       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.